Trial Profile
Single dose pharmacokinetic study of HP-3060 in pediatric patients with allergic rhinitis (2)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Emedastine (Primary)
- Indications Allergic rhinitis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Hisamitsu Pharmaceutical
- 06 Feb 2018 New trial record